May 19, 2023 – Mississauga, Ontario. CPL, a leading contract development and manufacturing organization (CDMO) of non-sterile liquid and topical drug products, recently completed successful inspections of its Mississauga facilities by both the Brazilian Regulatory Authority (ANVISA) and Health Canada.
Health Canada performed a routine inspection of CPL’s Meadowpine facility which includes the Quality Control analytical testing laboratory, skin testing laboratory, and microbiology laboratory. Following the inspection, CPL received a Compliant rating.
ANVISA audited CPL’s Danbro facility where its GMP manufacturing, packaging, and warehouse is located. CPL was seeking approval to manufacture and provide a prescription drug product to the Brazilian market on behalf of an existing customer. This was CPL’s first request to obtain approval from ANVISA to manufacture, package and test a product for the Brazilian market.
Our Compliant rating from Health Canada, together with the approval from ANVISA, reflects the pervasive Quality culture at CPL. We are thrilled to manufacture and supply our partner’s impactful therapies to a broader base of patients.
CPL is a leading contract development and manufacturing organization (CDMO) that provides development, manufacturing, packaging, and testing of non-sterile liquid and semi-solid pharmaceutical prescription and regulated OTC products.